10th International Congress of the Immunology of Diabetes Society in Malm?,Sweden

描述(由申请人提供)：作为糖尿病免疫学学会的创始主席和组委会现任联合主席，Lernmark博士向国立卫生研究院提交了一份赠款，以支持将于2009年5月13日星期三至5月16日星期六在瑞典马尔默举行的第十届国际糖尿病免疫学会大会。这是一次为期3.5天的会议，我们预计将有来自世界各地的约400名代表出席。入侵检测系统是一个从遗传和环境、发病机制、预测、预防、干预和治疗等方面探讨自身免疫性1型糖尿病病因学的国际论坛。国际会议在国际入侵检测系统的支持下每1.5年举行一次。上一次会议是2007年11月在佛罗里达州迈阿密举行的。在下一次会议中，我们将通过主旨演讲、研讨会、热点话题、辩论、口头演讲(10分钟和5分钟讨论)和海报展示相关领域的最新信息，重点介绍1型糖尿病的最新进展。口头报告将从提交的摘要中挑选出来。将有两个研讨会-一个是介绍由CDC和NIH支持的糖尿病自身抗体标准化计划(DASP)的结果，另一个是关于T细胞检测标准化的。他们相信，通过分享免疫学、遗传学和自身免疫学其他领域研究的最新进展，糖尿病免疫学社区将受益良多。因此，主要演讲者是这些研究领域的领先科学家。组委会正计划在互联网上直播讲座和演讲。这些讲座和演讲也将存档，并在有限的时间内以音频和CD形式在会议网站上提供。超过一半的补助金将用于向年轻调查人员提供旅行奖学金。年轻研究人员的旅行补助金将根据提交的摘要的数字评分来选择。额外的旅行资金将用于国际组委会在初步计划中概述的主要说明演讲演讲者、热点主题演讲者的座谈会演讲者。1型糖尿病是儿童最常见的慢性疾病，由胰岛β细胞的自身免疫攻击引起。这种情况在全球范围内呈上升趋势。1型糖尿病没有治愈的方法，患者的余生都依赖于每天注射胰岛素。每个患者都有晚期并发症影响血管、视网膜、肾脏和神经的风险。对于患者个人和社会来说，这是一种非常昂贵的疾病。

DESCRIPTION (provided by applicant): As the founding President of the Immunology of Diabetes Society and current co-chair of the Organizing Committee, Dr. Lernmark is submitting a grant to the National Institutes of Health for meeting support of the 10th International Congress of the Immunology of Diabetes Society (IDS) to be held in Malmoe, Sweden between Wednesday May 13 and Saturday May 16, 2009. This is a 3.5 day meeting that we expect to be attended by approximately 400 delegates from all over the world. The IDS is an international forum from all aspects of autoimmune type 1 diabetes - etiology- both genetic and environmental, pathogenesis, prediction, prevention, intervention and cure. International meetings are held under the IDS' auspice every 1.5 years. The last meeting was in Miami, FL in November, 2007. For this next meeting we are focusing on presenting recent advances in type 1 diabetes through key note address presentations, Symposia, Hot Topics, Debates, Oral presentations (10 min and 5 min discussion) and poster presentations the state of the art information within related fields. Oral presentations will be selected from submitted abstracts. There will be two workshops - one presenting results from the Diabetes Autoantibody Standardization Program (DASP) supported by the CDC and NIH and another about T cell Assay Standardization. The belief is that the diabetes immunology community will benefit much by sharing of information in the newest advances of other fields of research in immunology, genetics and autoimmunity. Hence the Key Address speakers are leading scientist in these fields of research. The organizing committee is planning to broadcast the lectures and presentations live on the internet. These lectures and presentations will also be archived and available on the conference website for a limited period of time streaming audio and on CD. More than half of the grant will be used to provide travel scholarships to young investigators. Travel grants for young investigators will be chosen by numerical ratings of submitted abstracts. Additional travel funding will be applied to Key Note address speakers, symposia speakers of Hot topics speakers chosen by the international organizing committee as outlined in the preliminary program. Type 1 diabetes, caused by an autoimmune attack on the pancreatic islet beta cells is the most common chronic disease in children. The incidence is increasing world-wide. There is no cure of type 1 diabetes and patients are dependent on daily insulin injections for the rest of their life-time. Every patients suffer the risk of late complications affecting the blood vessels, retina, kidney and nerves. It is a very expensive disease for the individual patient and for society.